Physician profile
Aamer Rahman
NPI 1235233453
$575.50
in general payments reported to CMS, 2019-2025
10 companies · $38.96 in 2025
The $38.96 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.61 · 2020: $13.32 · 2021: $72.06 · 2022: $70.05 · 2023: $148 · 2024: $174 · 2025: $38.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $171.50 | 2023-2024 | 2nd Gen Centrimag Primary Console, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $150.00 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.05 | 2022 | |
| W. L. Gore & Associates, INC. | $40.76 | 2021 | |
| Becton, Dickinson and Company | $38.96 | 2025 | Hemosphere |
| Astrazeneca Pharmaceuticals LP | $31.30 | 2021 | |
| La Jolla Pharmaceutical Company | $30.60 | 2019-2020 | |
| Nuwellis, INC. | $15.89 | 2019 | |
| Pfizer INC. | $13.77 | 2019 | |
| Glaxosmithkline, LLC. | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamer Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.